Role of the Doc2α-Munc13-1 interaction in the neurotransmitter release process

被引:68
作者
Mochida, S
Orita, S
Sakaguchi, G
Sasaki, T
Takai, Y
机构
[1] Tokyo Med Coll, Dept Physiol, Shinjuku Ku, Tokyo 1608402, Japan
[2] Sionogi Inst Med Sci, Settsu 5660022, Japan
[3] Osaka Univ, Sch Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan
关键词
C2; domain; neurotransmission; cholinergic synapse;
D O I
10.1073/pnas.95.19.11418
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Doc2 alpha and Munc13-1 proteins are highly concentrated on synaptic vesicles and the presynaptic plasma membrane, respectively, and have been implicated in Ca2+-dependent neurotransmitter release, Doc2 alpha interacts with Munc13-1 through the N-terminal region of Doc2 alpha (the Mid domain; amino acid residues 13-37), Here we examine whether the interaction between Doc2 alpha and Munc13-1 is required for Ca2+-dependent neurotransmitter release from intact neuron. A synthetic Mid peptide (the Mid peptide), but not a control mutated Mid peptide or a scrambled Mid peptide, inhibited the interaction between Doc2 alpha and Munc13-1 in vitro. Introduction of the Mid peptide into presynaptic neurons of cholinergic synapses, formed between rat superior cervical ganglion neurons, reversibly inhibited synaptic transmission evoked by action potentials, In contrast, the control peptides did not inhibit synaptic transmission. This inhibitory effect depended on the presynaptic activity and was affected by extracellular Ca2+ concentrations. The onset of the Mid peptide effect was shortened when the neuron was stimulated at a higher frequency, and the inhibition was more potent at 1 mM Ca2+ than at 5.1 mM Ca2+. These results suggest that the Doc2 alpha-Munc13-1 interaction plays a role in a step before the final fusion step of synaptic vesicles with the presynaptic plasma membrane in the evoked neurotransmitter release process.
引用
收藏
页码:11418 / 11422
页数:5
相关论文
共 24 条
[1]  
Betz A, 1997, J BIOL CHEM, V272, P2520
[2]   MAMMALIAN HOMOLOGS OF CAENORHABDITIS-ELEGANS UNC-13 GENE DEFINE NOVEL FAMILY OF C-2-DOMAIN PROTEINS [J].
BROSE, N ;
HOFMANN, K ;
HATA, Y ;
SUDHOF, TC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (42) :25273-25280
[3]   SYNAPTIC TRANSMISSION PERSISTS IN SYNAPTOTAGMIN MUTANTS OF DROSOPHILA [J].
DIANTONIO, A ;
PARFITT, KD ;
SCHWARZ, TL .
CELL, 1993, 73 (07) :1281-1290
[4]   SYNAPTOTAGMIN-I - A MAJOR CA2+ SENSOR FOR TRANSMITTER RELEASE AT A CENTRAL SYNAPSE [J].
GEPPERT, M ;
GODA, Y ;
HAMMER, RE ;
LI, C ;
ROSAHL, TW ;
STEVENS, CF ;
SUDHOF, TC .
CELL, 1994, 79 (04) :717-727
[5]   ADDITIONAL GENES WHICH RESULT IN AN ELEVATION OF ACETYLCHOLINE LEVELS BY MUTATIONS IN CAENORHABDITIS-ELEGANS [J].
HOSONO, R ;
KAMIYA, Y .
NEUROSCIENCE LETTERS, 1991, 128 (02) :243-244
[6]   CHARACTERIZATION OF THE CYSTEINE-RICH REGION OF THE CAENORHABDITIS-ELEGANS PROTEIN UNC-13 AS A HIGH-AFFINITY PHORBOL ESTER RECEPTOR - ANALYSIS OF LIGAND-BINDING INTERACTIONS, LIPID COFACTOR REQUIREMENTS, AND INHIBITOR SENSITIVITY [J].
KAZANIETZ, MG ;
LEWIN, NE ;
BRUNS, JD ;
BLUMBERG, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10777-10783
[7]   CA2+-DEPENDENT AND CA2+-INDEPENDENT ACTIVITIES OF NEURAL AND NONNEURAL SYNAPTOTAGMINS [J].
LI, C ;
ULLRICH, B ;
ZHANG, JZ ;
ANDERSON, RGW ;
BROSE, N ;
SUDHOF, TC .
NATURE, 1995, 375 (6532) :594-599
[8]   IMPAIRMENT OF SYNTAXIN BY BOTULINUM NEUROTOXIN C-1 OR ANTIBODIES INHIBITS ACETYLCHOLINE-RELEASE BUT NOT CA2+ CHANNEL ACTIVITY [J].
MOCHIDA, S ;
SAISU, H ;
KOBAYASHI, H ;
ABE, T .
NEUROSCIENCE, 1995, 65 (03) :905-915
[9]   MYOSIN-II IS INVOLVED IN TRANSMITTER RELEASE AT SYNAPSES FORMED BETWEEN RAT SYMPATHETIC NEURONS IN CULTURE [J].
MOCHIDA, S ;
KOBAYASHI, H ;
MATSUDA, Y ;
YUDA, Y ;
MURAMOTO, K ;
NONOMURA, Y .
NEURON, 1994, 13 (05) :1131-1142
[10]  
Mochida S, 1997, NEUROSCIENCE, V77, P937